Sodium-Glucose Co-transporter 2 Inhibitors treatment improve pancreatic β-cells function and insulin resistance in patients with Type 2 diabetes

被引:1
|
作者
Shi, Fang-Hong [1 ]
Xu, Li [2 ]
Shen, Long [2 ]
Cao, Min-Jia [1 ]
Li, Hao [3 ]
机构
[1] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Pharm, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Cardiol, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Clin Res Ward, Clin Res Ctr, Shanghai Childrens Med Ctr,Sch Med, Shanghai, Peoples R China
关键词
DOUBLE-BLIND; SENSITIVITY;
D O I
10.1016/j.ejim.2024.07.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:182 / 184
页数:3
相关论文
共 50 条
  • [31] Practical considerations for the use of sodium-glucose co-transporter type 2 inhibitors in treating hyperglycemia in type 2 diabetes
    Lam, Karen S. L.
    Chow, Chun Chung
    Tan, Kathryn C. B.
    Ma, Ronald C. W.
    Kong, Alice P. S.
    Tong, Peter C. Y.
    Tsang, Man Wo
    Chan, Tak Mao
    Tang, Sydney C. W.
    Lee, Ka Kui
    So, Wing Yee
    Tomlinson, Brian
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (06) : 1097 - 1108
  • [32] Sodium-glucose co-transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician
    Dandona, Paresh
    Chaudhuri, Ajay
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (05)
  • [33] Considerations for Initiating a Sodium-Glucose Co-Transporter 2 Inhibitor in Adults With Type 2 Diabetes Using Insulin
    Woo, Vincent C.
    Berard, Lori D.
    Bajaj, Harpreet S.
    Ekoe, Jean-Marie
    Senior, Peter A.
    CANADIAN JOURNAL OF DIABETES, 2018, 42 (01) : 88 - 93
  • [34] Pharmacodynamics, Efficacy and Safety of Sodium-Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
    Scheen, Andre J.
    DRUGS, 2015, 75 (01) : 33 - 59
  • [35] Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease
    Solomon, Joshua
    Festa, Maria Carolina
    Chatzizisis, Yiannis S.
    Samanta, Ratna
    Suri, Rita S.
    Mavrakanas, Thomas A.
    PHARMACOLOGY & THERAPEUTICS, 2023, 242
  • [36] Association between sodium-glucose co-transporter 2 inhibitors and heart failure readmission among patients with type 2 diabetes
    Park, Sohee
    Jeong, Han Eol
    Lee, Hyesung
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 329 - 329
  • [37] Use of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients With Type 2 Diabetes and the Incidence of Retinal Vein Occlusion in Taiwan
    Tsai, Hou-Ren
    Lin, Yu-Jie
    Yeh, Jih-, I
    Lin, Shu-Man
    Liu, Peter Pin-Sung
    Chang, Yung-Ching
    Lee, Yuan-Chieh
    Loh, Ching-Hui
    Huang, Huei-Kai
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (06)
  • [38] Renal effects of sodium-glucose co-transporter 2 inhibitors in Japanese type 2 diabetes patients with chronic kidney disease
    Kobayashi, K.
    Toyoda, M.
    Hatori, N.
    Sato, K.
    Tamura, K.
    Miyakawa, M.
    DIABETOLOGIA, 2019, 62 : S485 - S485
  • [39] Differential Effects of Diabetes and Sodium-Glucose Co-Transporter 2 Inhibitors on Skeletal Microstructure
    Agarwal, Sanchita
    Okazaki, Keity
    Kondapalli, Ananya
    Germosen, Carmen
    Colon, Ivelisse
    Kil, Nayoung
    Rosillo, Isabella
    Bucovsky, Mariana
    Walker, Marcella
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 93 - 93
  • [40] The Novel Role of the Kidney in Diabetes Management: Sodium-Glucose Co-Transporter 2 Inhibitors
    Swislocki, Arthur L. M.
    Jialal, Ishwarlal
    METABOLIC SYNDROME AND RELATED DISORDERS, 2015, 13 (07) : 287 - 291